Tema Neuroscience and Mental Health ETF Rating $23.36 -0.04 (-0.18%) Closing price 07/25/2025 02:08 PM EasternExtended Trading$23.36 +0.00 (+0.00%) As of 07/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Neuroscience and Mental Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MNTL Aggregate RatingModerate Buy 2.82Holdings in MNTL have an aggregate rating of Moderate Buy based on 604 analyst ratings issued in the past year covering 39 companies (93.0% of the portfolio).MNTL Aggregate Price Target$23.36High Prediction$23.36Average Prediction$23.36Low Prediction$23.36Holdings in MNTL have an aggregate price target of $23.36 and a range of $23.36 to $23.36 covering 39 companies (93.0% of the portfolio).MNTL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Neuroscience and Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 MNTL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.43%VRTXVertex Pharmaceuticals$469.65-0.6%4.3226 of 5 stars2.52$512.30 9.1%27Positive NewsAnalyst Revision8.10%REGNRegeneron Pharmaceuticals$563.10-0.3%4.8268 of 5 stars2.75$828.86 47.2%24Trending NewsUpcoming EarningsAnalyst Forecast6.49%ALNYAlnylam Pharmaceuticals$328.81+0.2%4.0702 of 5 stars2.81$347.75 5.8%26News CoveragePositive NewsUpcoming Earnings5.02%NBIXNeurocrine Biosciences$132.14+0.4%4.4413 of 5 stars2.88$163.87 24.0%24Upcoming EarningsAnalyst Forecast4.89%TEVATeva Pharmaceutical Industries$16.53+1.2%4.0145 of 5 stars3.25$24.71 49.5%8Upcoming EarningsAnalyst Upgrade4.82%ARGXargenex$591.99+0.0%3.6719 of 5 stars3.10$728.06 23.0%21Trending NewsUpcoming EarningsAnalyst Revision4.23%LLYEli Lilly and Company$811.73+0.8%4.905 of 5 stars2.75$1,012.56 24.7%20Trending NewsAnalyst Upgrade3.82%CRNXCrinetics Pharmaceuticals$30.99+1.9%3.685 of 5 stars2.80$69.50 124.3%10Positive News3.60%IONSIonis Pharmaceuticals$42.24+0.2%4.5355 of 5 stars2.62$55.67 31.8%13News CoverageUpcoming Earnings3.41%SYKStryker$403.34+1.7%4.537 of 5 stars2.79$428.55 6.3%19Positive NewsUpcoming Earnings3.31%BIIBBiogen$131.52-0.8%4.8086 of 5 stars2.34$186.37 41.7%32Upcoming EarningsAnalyst Revision2.61%MDTMedtronic$92.91+0.6%4.6578 of 5 stars2.59$98.19 5.7%22Positive News2.42%CPRXCatalyst Pharmaceuticals$20.97-0.2%4.9239 of 5 stars3.25$32.83 56.6%8News CoveragePositive NewsAnalyst Revision2.40%AXSMAxsome Therapeutics$100.83-3.9%4.744 of 5 stars3.06$172.33 70.9%16News CoveragePositive NewsAnalyst Revision2.25%DNLIDenali Therapeutics$13.67-4.5%4.2607 of 5 stars3.06$33.71 146.6%17News CoveragePositive NewsUpcoming Earnings2.24%ACADACADIA Pharmaceuticals$23.25+0.9%4.1521 of 5 stars2.71$28.13 21.0%17Positive NewsAnalyst Forecast2.03%XENEXenon Pharmaceuticals$30.30-2.3%3.7574 of 5 stars3.00$54.82 80.9%12Positive NewsOptions Volume1.85%DXCMDexCom$88.99+2.6%4.7259 of 5 stars2.90$98.72 10.9%20Upcoming Earnings1.83%JAZZJazz Pharmaceuticals$118.23+0.2%4.8614 of 5 stars2.93$181.64 53.6%14Analyst Forecast1.71%ALKSAlkermes$26.13-1.5%4.7871 of 5 stars2.83$40.92 56.6%12Upcoming Earnings1.71%SRRKScholar Rock$38.95-0.4%3.4303 of 5 stars3.13$42.67 9.5%81.57%RNAAvidity Biosciences$36.27+9.2%2.15 of 5 stars3.06$66.35 82.9%17News CoverageHigh Trading Volume1.53%PENPenumbra$233.17+1.3%4.4474 of 5 stars2.94$305.07 30.8%18Positive NewsUpcoming EarningsInsider Trade1.53%PTCTPTC Therapeutics$44.74-3.4%4.4429 of 5 stars2.67$65.00 45.3%15News CoverageAnalyst Revision1.53%OPCHOption Care Health$29.69+0.7%4.5403 of 5 stars2.88$35.50 19.6%8Positive NewsUpcoming Earnings1.04%DAWNDay One Biopharmaceuticals$7.23+0.3%2.7248 of 5 stars3.14$29.00 301.1%7News Coverage0.98%IMVTImmunovant$16.95-7.5%1.2768 of 5 stars2.82$36.30 114.2%11News CoverageGap DownHigh Trading Volume0.82%NTLAIntellia Therapeutics$13.60+6.4%4.5268 of 5 stars2.65$33.37 145.4%20News CoverageInsider Trade0.73%TALKTalkspace$2.523.5386 of 5 stars3.00$4.50 78.6%7News Coverage0.60%ACHCAcadia Healthcare$22.25+2.3%4.0451 of 5 stars2.60$47.94 115.5%10News CoverageAnalyst Downgrade0.56%BHVNBiohaven$13.50-1.4%2.3183 of 5 stars3.07$58.46 333.2%15Trending News0.49%PRAXPraxis Precision Medicines$59.22+2.1%2.3746 of 5 stars2.78$94.11 58.9%90.48%VYGRVoyager Therapeutics$3.24-2.1%3.9075 of 5 stars3.13$13.39 313.3%80.42%DYNDyne Therapeutics$9.95+7.7%3.8285 of 5 stars3.00$40.63 308.3%170.42%SLDBSolid Biosciences$7.00+4.8%3.0988 of 5 stars3.17$15.10 115.7%120.40%PRTAProthena$6.68-0.3%3.7494 of 5 stars2.33$31.50 371.6%9Positive News0.35%SRPTSarepta Therapeutics$11.93-7.4%4.6939 of 5 stars2.11$51.42 331.0%28Trending NewsAnalyst DowngradeGap Down0.18%RAPPRapport Therapeutics$16.05-3.4%1.6466 of 5 stars3.00$28.00 74.5%1News Coverage0.16%ARVNArvinas$7.84-0.6%4.031 of 5 stars2.55$20.29 158.8%22News CoverageUpcoming Earnings This page (NASDAQ:MNTL) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
